| 8:00 am | Early-Bird Conference (Summary of ASN Highlights) |
| 9:00 am | Opening Remarks: Dr. Michel Vallée, JQH president
Welcoming Remarks by the President of the Canadian Society of Nephrology (CSN): Dr. Claudio Rigatto
|
| 9:15 – 10:00 am | The Health of Aboriginal Peoples in the HD Setting
Dr. Murray Vasilevsky conference presented in English
- Discuss the prevalence of Aboriginal patients in the hemodialysis setting in Quebec as well as problems that commonly occur
- Examine the obstacles Aboriginal patients face
- Better understand the Aboriginal patient’s perspective
|
| 10:55 – 10:45 am | Antibiotic Therapy in Hemodialysis: Clinical Pearls, Pitfalls and Perils
Jean-François Tessier, pharm.
- Define antibiotherapy through an examination of its various applications
- Explain how penicillin allergy impacts patient management in the hemodialysis setting
- Apply pharmacokinetic and pharmacodynamic concepts to antibiotherapy to better meet the needs of HD patients
|
| 10:45 - 11:00 am | Health Break |
| 11:00 – noon | Pierre-Nantel Conference
pruritus in the HD Patient: a real head-scratcher
Dr. Claudio Rigatto conference presented in English
- To review the epidemiology of this problem: prevalence, risk factors, associated morbidity and impact on patient quality of life
- To discuss the pathophysiology of pruritus and the evolving knowledge on this topic
- To provide an update on the treatment options of pruritus with emphasis on the relative efficacy and safety of these treatments
|
| noon - 1:00 pm | Lunch |
| 1:00 –1:45 pm | The Challenge of Patients with Heart Failure in Hemodialysis
Dr. Michel White
- Explain the pathophysiology of the HF patient undergoing hemodialysis
- Organize a response to the specific needs of HF patients in the hemodialysis setting
- Recognize the grey areas and the challenges in dealing with HF patients receiving HD
|
| 1:45 –2:30 pm | What’s new in acute renal replacement therapy?
Dr. Philippe Lachance
- Explain when to begin and when to stop acute renal replacement therapy
- Discuss the latest developments in anticoagulation therapy in the acute renal replacement setting
- Evaluate a new initiative in acute renal replacement therapy
|
| 2:30 pm | Closing Remarks: Dr Michel Vallée
|